Status:
COMPLETED
Differential Responses to Drugs and Sweet Tastes
Lead Sponsor:
University of Chicago
Conditions:
Bipolar II Disorder
Eligibility:
All Genders
18-19 years
Phase:
PHASE1
Brief Summary
Young adults who exhibit "bipolar phenotype" (BPP), defined as occasional episodes of mood elevation and heightened activity, are at risk for several psychiatric disorders, including problem use of dr...
Detailed Description
This study will extend the understanding of risk factors for drug or alcohol misuse, or other reward-related behaviors. The investigators previously showed that individuals who report occasional feeli...
Eligibility Criteria
Inclusion
- Aged 18-19 years old
- BMI of 19-26
- Physical/EKG/Medical History/Medications Approved by Physician for d-amphetamine
- at least High School education
- Fluent in English
Exclusion
- No Current Mood, Anxiety, Eating or Psychotic Disorder
- No current psychotropic medication
- No Recent Drug Dependence
- \< 4 alcoholic drinks/day for males; \< 3 alcoholic drinks/day for females (monthly average)
- No weekly (or more frequent) illicit drug use
- No women who are pregnant, nursing, or planning pregnancy within 3 months (birth control is okay)
Key Trial Info
Start Date :
February 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2018
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT03810703
Start Date
February 9 2017
End Date
August 9 2018
Last Update
February 22 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medical Center - Human Behavioral Pharmacology Lab
Chicago, Illinois, United States, 60637
2
University of Chicago
Chicago, Illinois, United States, 60637